Close Menu

immunocompromised

The Stanford spinout has launched an infectious disease test that sequences cell-free pathogen DNA to diagnose sepsis in immunocompromised patients.

At the recent IDWeek conference, company collaborators presented early validation data on a blood-based assay for cell-free microbial DNA.

Researchers used exome sequencing to pinpoint DOCK2 mutations as causative of early childhood immune deficiency that leads to severe infections. 

BD Diagnostics and Italian biotech firm Biodiversity said today that they will collaborate to develop a comprehensive molecular diagnostic menu for testing immunocompromised patients on the BD Max system, adding to the pipeline of assay content for the recently launched platform.

In addition, Argene will provide BioMérieux with a portfolio of molecular tests for diagnosing infectious diseases in transplant and other immunocompromised patients.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.